Skip to main content
Erschienen in: Journal of General Internal Medicine 1/2014

01.01.2014 | Original Research

Racial/Ethnic Differences in Trust in Health Care: HIV Conspiracy Beliefs and Vaccine Research Participation

verfasst von: Ryan P. Westergaard, MD, PhD, MPH, Mary Catherine Beach, MD, MPH, Somnath Saha, MD, MPH, Elizabeth A. Jacobs, MD, MAPP

Erschienen in: Journal of General Internal Medicine | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

ABSTRACT

BACKGROUND

Prior research has documented a high prevalence of conspiracy beliefs about the origin of the human immunodeficiency virus (HIV) and the role of the government in the acquired immunodeficiency syndrome (AIDS) epidemic, particularly among racial and ethnic minorities in the United States. Whether such beliefs are a barrier to participation in HIV prevention research is not known.

OBJECTIVE

To understand the prevalence of HIV conspiracy beliefs and their relationship to willingness to participate in HIV vaccine research among three racial/ethnic groups.

DESIGN

Cross-sectional survey.

PARTICIPANTS

Six hundred and one community-recruited volunteers (33.0 % White, 32.5 % Mexican American, and 34.5 % African American).

MAIN MEASURES

We evaluated the level of agreement with six previously described HIV conspiracy beliefs, trust in medical research, and willingness to participate in HIV vaccine research. Multivariate models were used to compare these parameters among the three racial/ethnic groups while controlling for the potential confounding effects of socioeconomic status, access to health care, and other demographic factors.

RESULTS

African Americans, Mexican Americans, and whites had similar levels of distrust in medical research. African and Mexican Americans were more likely to endorse one or more of six HIV conspiracy beliefs than whites (59.0 % and 58.6 % versus 38.9 %, respectively, P < 0.001), but were significantly more willing to participate in HIV vaccine research (ORs 1.58, CI 1.10–2.25 and 2.53, CI 1.75–3.66, respectively). Among respondents of all racial/ethnic groups, endorsing HIV conspiracy beliefs was not associated with willingness to participate in research.

CONCLUSIONS

HIV conspiracy beliefs, while common among all racial and ethnic groups in the United States, do not preclude willingness to participate in HIV prevention research.
Literatur
1.
Zurück zum Zitat Centers for Disease Control and Prevention. Racial/ethnic disparities in diagnoses of HIV/AIDS—33 states, 2001–2004. MMWR Morb Mortal Wkly Rep. 2006;55(5):121–125. Centers for Disease Control and Prevention. Racial/ethnic disparities in diagnoses of HIV/AIDS—33 states, 2001–2004. MMWR Morb Mortal Wkly Rep. 2006;55(5):121–125.
2.
Zurück zum Zitat Centers for Disease Control and Prevention. Racial/ethnic disparities in diagnoses of HIV/AIDS—33 states, 2001–2005. MMWR Morb Mortal Wkly Rep. 2007;56(9):189–193. Centers for Disease Control and Prevention. Racial/ethnic disparities in diagnoses of HIV/AIDS—33 states, 2001–2005. MMWR Morb Mortal Wkly Rep. 2007;56(9):189–193.
4.
Zurück zum Zitat Linley L, Prejean J, An Q, Chen M, Hall HI. Racial/ethnic disparities in hiv diagnoses among persons aged 50 years and older in 37 US States, 2005–2008. Am J Public Health. 2012;102(8):1527–1534.PubMedCrossRef Linley L, Prejean J, An Q, Chen M, Hall HI. Racial/ethnic disparities in hiv diagnoses among persons aged 50 years and older in 37 US States, 2005–2008. Am J Public Health. 2012;102(8):1527–1534.PubMedCrossRef
5.
Zurück zum Zitat McDavid K, Li J, Lee LM. Racial and ethnic disparities in HIV diagnoses for women in the United States. J Acquir Immune Defic Syndr. 2006;42(1):101–107.PubMedCrossRef McDavid K, Li J, Lee LM. Racial and ethnic disparities in HIV diagnoses for women in the United States. J Acquir Immune Defic Syndr. 2006;42(1):101–107.PubMedCrossRef
6.
Zurück zum Zitat Hall HI, Byers RH, Ling Q, Espinoza L. Racial/ethnic and age disparities in HIV prevalence and disease progression among men who have sex with men in the United States. Am J Public Health. 2007;97(6):1060–1066.PubMedCrossRef Hall HI, Byers RH, Ling Q, Espinoza L. Racial/ethnic and age disparities in HIV prevalence and disease progression among men who have sex with men in the United States. Am J Public Health. 2007;97(6):1060–1066.PubMedCrossRef
7.
Zurück zum Zitat Millett GA, Peterson JL, Flores SA, et al. Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet. 2012;380(9839):341–348.PubMedCrossRef Millett GA, Peterson JL, Flores SA, et al. Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet. 2012;380(9839):341–348.PubMedCrossRef
8.
9.
Zurück zum Zitat Fleishman JA, Yehia BR, Moore RD, Korthuis PT, Gebo KA. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr. 2012;60(3):249–259. Fleishman JA, Yehia BR, Moore RD, Korthuis PT, Gebo KA. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr. 2012;60(3):249–259.
10.
Zurück zum Zitat Yehia BR, Fleishman JA, Metlay JP, Moore RD, Gebo KA. Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA. 2012;308(4):339–342.PubMedCentralPubMedCrossRef Yehia BR, Fleishman JA, Metlay JP, Moore RD, Gebo KA. Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA. 2012;308(4):339–342.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Giordano TP, Bartsch G, Zhang Y, et al. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDS. 2010;24(5):287–295. Giordano TP, Bartsch G, Zhang Y, et al. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDS. 2010;24(5):287–295.
12.
Zurück zum Zitat Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr. 2009;50(1):100–108.PubMedCentralPubMedCrossRef Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr. 2009;50(1):100–108.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Gifford AL, Cunningham WE, Heslin KC, et al. Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002;346(18):1373–1382.PubMedCrossRef Gifford AL, Cunningham WE, Heslin KC, et al. Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002;346(18):1373–1382.PubMedCrossRef
14.
Zurück zum Zitat Stone VE, Mauch MY, Steger K, Janas SF, Craven DE. Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J Gen Intern Med Mar. 1997;12(3):150–157. Stone VE, Mauch MY, Steger K, Janas SF, Craven DE. Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J Gen Intern Med Mar. 1997;12(3):150–157.
15.
Zurück zum Zitat Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87(11):1773–1778.PubMedCrossRef Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87(11):1773–1778.PubMedCrossRef
16.
Zurück zum Zitat Gamble VN. The Tuskegee Syphilis study and women’s health. J Am Med Women’s Assoc. 1997;52(4):195–196. Gamble VN. The Tuskegee Syphilis study and women’s health. J Am Med Women’s Assoc. 1997;52(4):195–196.
17.
Zurück zum Zitat Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine. 2008;87(1):1–9.PubMedCrossRef Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine. 2008;87(1):1–9.PubMedCrossRef
18.
Zurück zum Zitat Harris Y, Gorelick PB, Samuels P, Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc. 1996;88(10):630–634.PubMed Harris Y, Gorelick PB, Samuels P, Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc. 1996;88(10):630–634.PubMed
19.
Zurück zum Zitat Mouton CP, Harris S, Rovi S, Solorzano P, Johnson MS. Barriers to black women’s participation in cancer clinical trials. J Natl Med Assoc. 1997;89(11):721–727.PubMed Mouton CP, Harris S, Rovi S, Solorzano P, Johnson MS. Barriers to black women’s participation in cancer clinical trials. J Natl Med Assoc. 1997;89(11):721–727.PubMed
20.
Zurück zum Zitat Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol. 2002;12(4):248–256.PubMedCrossRef Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol. 2002;12(4):248–256.PubMedCrossRef
21.
Zurück zum Zitat Gorelick PB, Harris Y, Burnett B, Bonecutter FJ. The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. An interim report from the African-American Antiplatelet Stroke Prevention Study (AAASPS). J Natl Med Assoc. 1998;90(3):141–145.PubMed Gorelick PB, Harris Y, Burnett B, Bonecutter FJ. The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. An interim report from the African-American Antiplatelet Stroke Prevention Study (AAASPS). J Natl Med Assoc. 1998;90(3):141–145.PubMed
22.
Zurück zum Zitat Volkmann ER, Claiborne D, Currier JS. Determinants of participation in HIV clinical trials: the importance of patients’ trust in their provider. HIV Clin Trials. 2009;10(2):104–109.PubMedCrossRef Volkmann ER, Claiborne D, Currier JS. Determinants of participation in HIV clinical trials: the importance of patients’ trust in their provider. HIV Clin Trials. 2009;10(2):104–109.PubMedCrossRef
23.
Zurück zum Zitat Sengupta S, Strauss RP, DeVellis R, Quinn SC, DeVellis B, Ware WB. Factors affecting African-American participation in AIDS research. J Acquir Immune Defic Syndr. 2000;24(3):275–284.PubMed Sengupta S, Strauss RP, DeVellis R, Quinn SC, DeVellis B, Ware WB. Factors affecting African-American participation in AIDS research. J Acquir Immune Defic Syndr. 2000;24(3):275–284.PubMed
24.
Zurück zum Zitat Jones JH. Bad blood: the Tuskegee Syphilis experiment. New and expanded edition. New York: Te Free Press; 1993. Jones JH. Bad blood: the Tuskegee Syphilis experiment. New and expanded edition. New York: Te Free Press; 1993.
25.
Zurück zum Zitat Klonoff EA, Landrine H. Do blacks believe that HIV/AIDS is a government conspiracy against them? Prev Med. 1999;28(5):451–457.PubMedCrossRef Klonoff EA, Landrine H. Do blacks believe that HIV/AIDS is a government conspiracy against them? Prev Med. 1999;28(5):451–457.PubMedCrossRef
26.
Zurück zum Zitat Herek GM, Capitanio JP. Conspiracies, contagion, and compassion: trust and public reactions to AIDS. AIDS Educ Prev. 1994;6(4):365–375.PubMed Herek GM, Capitanio JP. Conspiracies, contagion, and compassion: trust and public reactions to AIDS. AIDS Educ Prev. 1994;6(4):365–375.PubMed
27.
Zurück zum Zitat Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Acquir Immune Defic Syndr. 2005;38(2):213–218.PubMedCrossRef Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Acquir Immune Defic Syndr. 2005;38(2):213–218.PubMedCrossRef
28.
Zurück zum Zitat Ross MW, Essien EJ, Torres I. Conspiracy beliefs about the origin of HIV/AIDS in four racial/ethnic groups. J Acquir Immune Defic Syndr. 2006;41(3):342–344.PubMedCentralPubMedCrossRef Ross MW, Essien EJ, Torres I. Conspiracy beliefs about the origin of HIV/AIDS in four racial/ethnic groups. J Acquir Immune Defic Syndr. 2006;41(3):342–344.PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndr. 2010;53(5):648–655. Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndr. 2010;53(5):648–655.
30.
Zurück zum Zitat Clark A, Mayben JK, Hartman C, Kallen MA, Giordano TP. Conspiracy beliefs about HIV infection are common but not associated with delayed diagnosis or adherence to care. AIDS Patient Care STDS. 2008;22(9):753–759.PubMedCrossRef Clark A, Mayben JK, Hartman C, Kallen MA, Giordano TP. Conspiracy beliefs about HIV infection are common but not associated with delayed diagnosis or adherence to care. AIDS Patient Care STDS. 2008;22(9):753–759.PubMedCrossRef
31.
Zurück zum Zitat Bogart LM, Galvan FH, Wagner GJ, Klein DJ. Longitudinal association of HIV conspiracy beliefs with sexual risk among black males living with HIV. AIDS Behav. 2011;15(6):1180–1186.PubMedCentralPubMedCrossRef Bogart LM, Galvan FH, Wagner GJ, Klein DJ. Longitudinal association of HIV conspiracy beliefs with sexual risk among black males living with HIV. AIDS Behav. 2011;15(6):1180–1186.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Gray R, Kigozi G, Kong X, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS. 2012;26(5):609–615.PubMedCrossRef Gray R, Kigozi G, Kong X, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS. 2012;26(5):609–615.PubMedCrossRef
33.
Zurück zum Zitat Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–666.PubMedCrossRef Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–666.PubMedCrossRef
34.
Zurück zum Zitat Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–1174.PubMedCentralPubMedCrossRef Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–1174.PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–2599.PubMedCentralPubMedCrossRef Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–2599.PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.PubMedCentralPubMedCrossRef Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. N Eng J Med. 2011;0(0). Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. N Eng J Med. 2011;0(0).
38.
Zurück zum Zitat Johnston MI, Fauci AS. HIV vaccine development–improving on natural immunity. N Engl J Med. 2011;365(10):873–875.PubMedCrossRef Johnston MI, Fauci AS. HIV vaccine development–improving on natural immunity. N Engl J Med. 2011;365(10):873–875.PubMedCrossRef
39.
Zurück zum Zitat Hall MA, Camacho F, Lawlor JS, Depuy V, Sugarman J, Weinfurt K. Measuring trust in medical researchers. Med Care. 2006;44(11):1048–1053.PubMedCrossRef Hall MA, Camacho F, Lawlor JS, Depuy V, Sugarman J, Weinfurt K. Measuring trust in medical researchers. Med Care. 2006;44(11):1048–1053.PubMedCrossRef
40.
Zurück zum Zitat Bogart LM, Thorburn S. Relationship of African Americans’ sociodemographic characteristics to belief in conspiracies about HIV/AIDS and birth control. J Natl Med Assoc. 2006;98(7):1144–1150.PubMed Bogart LM, Thorburn S. Relationship of African Americans’ sociodemographic characteristics to belief in conspiracies about HIV/AIDS and birth control. J Natl Med Assoc. 2006;98(7):1144–1150.PubMed
42.
Zurück zum Zitat Garber M, Hanusa BH, Switzer GE, Mellors J, Arnold RM. HIV-infected African Americans are willing to participate in HIV treatment trials. J Gen Intern Med. 2007;22(1):17–42.PubMedCentralPubMedCrossRef Garber M, Hanusa BH, Switzer GE, Mellors J, Arnold RM. HIV-infected African Americans are willing to participate in HIV treatment trials. J Gen Intern Med. 2007;22(1):17–42.PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Adeyemi OF, Evans AT, Bahk M. HIV-infected adults from minority ethnic groups are willing to participate in research if asked. AIDS Patient Care STDS. 2009;23(10):859–865.PubMedCrossRef Adeyemi OF, Evans AT, Bahk M. HIV-infected adults from minority ethnic groups are willing to participate in research if asked. AIDS Patient Care STDS. 2009;23(10):859–865.PubMedCrossRef
44.
45.
Zurück zum Zitat Newman PA, Duan N, Rudy ET, Roberts KJ, Swendeman D. Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV. J Acquir Immune Defic Syndr. 2004;37(3):1393–1403.PubMedCrossRef Newman PA, Duan N, Rudy ET, Roberts KJ, Swendeman D. Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV. J Acquir Immune Defic Syndr. 2004;37(3):1393–1403.PubMedCrossRef
46.
Zurück zum Zitat Newman PA, Duan N, Roberts KJ, et al. HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. J Acquir Immune Defic Syndr. 2006;41(2):210–217.PubMedCrossRef Newman PA, Duan N, Roberts KJ, et al. HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. J Acquir Immune Defic Syndr. 2006;41(2):210–217.PubMedCrossRef
Metadaten
Titel
Racial/Ethnic Differences in Trust in Health Care: HIV Conspiracy Beliefs and Vaccine Research Participation
verfasst von
Ryan P. Westergaard, MD, PhD, MPH
Mary Catherine Beach, MD, MPH
Somnath Saha, MD, MPH
Elizabeth A. Jacobs, MD, MAPP
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 1/2014
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2554-6

Weitere Artikel der Ausgabe 1/2014

Journal of General Internal Medicine 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

22.05.2024 Obstipation Nachrichten

Bei chronischer Verstopfung wirken Kiwis offenbar besser als Flohsamenschalen. Das zeigen die Daten aus einer randomisierten Studie, die der Gastroenterologe Oliver Pech beim Praxis-Update vorstellte.

So häufig greift rheumatoide Arthritis auf Organe über

21.05.2024 Rheumatoide Arthritis Nachrichten

Im Verlauf von rheumatoider Arthritis entwickeln viele Patienten extraartikuläre Manifestationen. Schwedische Forscher haben sich mit der Inzidenz und den Risikofaktoren befasst.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.